fbpx
QQQ
+ 7.05
312.29
+ 2.21%
DIA
+ 4.00
336.23
+ 1.18%
SPY
+ 6.32
403.85
+ 1.54%
TLT
+ 1.27
134.54
+ 0.94%
GLD
+ 1.54
169.61
+ 0.9%

How Medical Marijuana Can Help With ALS (Or Lou Gehrig's Disease)

July 18, 2020 11:55 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
How Medical Marijuana Can Help With ALS (Or Lou Gehrig's Disease)

This article was originally published on The Fresh Toast, and appears here with permission.

Hundreds of studies have looked into the benefits of THC and CBD on pain and overall health, and in the last decade alone, dozens have focused on the effect of cannabinoids on ALS. 

One of the most widely misunderstood disorders, amyotrophic lateral sclerosis (ALS,) seems to make headlines for the beautiful lives it has taken, including famous baseball legend Lou Gehrig. 

As a progressive neurodegenerative disease, ALS causes patients to lose control of bodily functions such as eating, speaking, and breathing, creating heartache for those who battle the disease. An estimated 30,000 Americans are living with ALS, with 5,000 individuals diagnosed per year, according to the ALS Association. A humbling statistic also is present with ALS, as it was found in a study that veterans are two-times more likely to be diagnosed with ALS over the general public. 

Hundreds of studies have looked into the benefits of THC and CBD on pain and overall health, and in the last decade alone, dozens have focused on the effect of cannabinoids on ALS

RELATED: Cannabis And Lou Gehrig’s Disease: Here’s What You Should Know

Cannabis And Lou Gehrig's Disease

Photo by Bru-nO via Pixabay

Here are two promising studies about THC and CBD’s effects on those battling ALS: 

  •  Cannabis and amyotrophic lateral sclerosis: The US National Library of Medicine National Institutes of Health summarized, “Preclinical data indicate that cannabis has powerful antioxidative, anti-inflammatory, and neuroprotective effects,” when it was added to ALS therapies. 
  •  Neurological aspects of medical use of CBD: The US National Library of Medicine National Institutes of Health found that “Pre-clinical evidence largely shows that CBD can produce beneficial effects in MS patients.” 

While on-going, studies continue to show promise for ALS. The Neural Regeneration Research Journal recently published a piece on ALS and cannabis. ALSToday shares:

“According to a single observational study of patients with ALS, only the 10 percent who admitted consuming cannabis revealed moderate relief of several symptoms, including appetite loss, depression, pain and drooling.” 

While ultimately research is focused on eliminating ALS altogether, for those suffering and caregivers watching, CBD and cannabinoids may help ease symptoms for a better quality of life.

By The Fresh Toast's Kate-Madonna Hindes, provided exclusively to Benzinga Cannabis.

Continue reading:


Related Articles

A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies

As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small. read more

Zenabis Global's JV To Launch Operations In Malta

Zenabis Global Inc.'s (TSX: ZENA) Maltese joint venture, ZenPharm Limited, was given the green light to produce cannabis for medicinal and research purposes in the Mediterranean island country. read more

Cannabis Movers & Shakers: CMW Media, Phyto Extractions, Organigram, GrowGen, Harborside

CMW Media Hires Jon Lindsay Phillips As CGO CMW Media, a cannabis and emerging market-focused marketing and communication agency, welcomed Jon Lindsay Phillips to serve as its chief growth officer. Phillips brings with him more than twelve years of experience, having lead dynamic communications agencies. read more

Supreme Cannabis Q3 Revenue Plunges Ahead Of Merger With Canopy Growth

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) reported Thursday having earned $16.8 million in gross revenue in the third quarter of 2021, representing a sequential decrease of 22.5%. read more